Skip to main content
Journal of Pharmaceutical Policy and Practice logoLink to Journal of Pharmaceutical Policy and Practice
. 2021 Dec 24;14:111. doi: 10.1186/s40545-021-00393-w

Prevalence and risk factors of burnout among Lebanese community pharmacists in the era of COVID-19 pandemic: results from the first national cross-sectional survey

Dalal Youssef 1,2,3,, Janet Youssef 4, Hamad Hassan 5, Linda Abou-Abbas 6,7
PMCID: PMC8704065  PMID: 34952654

Abstract

Background

Community pharmacists (CPs) are increasingly facing occupational challenges as a result of the COVID-19 pandemic, putting them at high risk of burnout. This study aimed to assess the prevalence of burnout among Lebanese CPs during the COVID-19 pandemic and to identify its associated factors.

Methods

An online survey was conducted among Lebanese CPs between February 1st and March 30, 2021. Collected data included information on sociodemographic characteristics, exposure and work-related variables, the Copenhagen burnout inventory (CBI), and the COVID-19 threat perception scale. Prevalence of burnout was calculated. Multiple logistic regressions were performed to identify the factors associated with the three burnout domains.

Results

A total of 387 CPs participated in the survey. Of the total, 53.7% were females; and 43.2% were aged less than 40 years old. The prevalence of moderate-to-high personal, work-related and client-related burnout was 77.8%, 76.8, and 89.7%, respectively. Younger age, staff pharmacist, working more than 40 h per week, high perceived COVID-19 threat were associated with a moderate-to-high likelihood of burnout in all three domains. However, altruistically accepting the risks of caring for COVID-19 patients was the only variable that was associated with a lower likelihood of burnout in all three domains.

Conclusion

An alarming prevalence of personal, work-related and client-related burnout was revealed among Lebanese CPs. This study has many implications for practice and provides a framework for establishing policy interventions to reduce burnout levels among Lebanese CPs. Preventive strategies and interventions on individual and organizational basis are recommended.

Keywords: Burnout, Community pharmacists, COVID-19, Prevalence, Risk factors, Lebanon

Background

Burnout syndrome is affecting all healthcare workforce disciplines and community-based pharmacists (CPs), representing the third largest health care professional group outnumbered only by physicians and nurses, are no exception [14]. Over the last three decades, the role of the community pharmacist (CPs) has evolved from distributing drugs to improving patient-centered care and pharmacist–patient engagement [5]. While the types of patient care services provided by CPs vary greatly by country, an increasing number of pharmacists are providing critical emergency medication refills, prescription renewals/extensions, dose or formulation changes, therapeutic substitution, prescribing for minor ailments, initiation of prescription drug therapy, ordering and interpreting laboratory tests, immunization and drug administration. However, the transition from product-based to service-based care was confronted by several challenges experienced through interacting with the workplace environment [6]. These challenges were described as inducing psychosocial stress and burnout [710]. Of note, stressors confronted by CPs mirror those of physicians, including an ineffective work environment, the burden of non-clinical and administrative duties, and excessive workloads combined with lack of resources [11]. The negative consequences of CPs burnout could affect patient care [12] and can lead to CPs poor self-care, substance abuse, depression, and suicidal ideation [8, 1315].

In the context of CPs population, burnout is not deeply explored. A systematic review appraised that the prevalence of overall burnout among pharmacists ranged from 52 to 61% [16]. Another study conducted before the Coronavirus disease (COVID-19) pandemic with the assistance of the American Pharmacists Association (APhA) has estimated that 75% of CPS suffered from burnout [17]. Given the large heterogeneity in the role and responsibilities of CPs within health systems and across practice settings [18], it is essential to take into consideration differences among pharmacy practice settings that could contribute to differing levels of burnout.

Since the onset of COVID-19, increased demand for medical services has strained worldwide the health care systems to their limits [19]. Subsequently, the majority of non-urgent operations and medical services in health facilities were canceled or suspended to allow the healthcare system to manage the soar of severe cases of COVID-19. As result, the public turned to CPs since they remain the most accessible face-to-face primary healthcare provider [20]. Some countries have recognized the pharmacy as an ideal access point for patients and allowed CPs to run COVID-19 testing along with COVID-19 vaccination services. These inflicted duties on the shoulder of CPs have increased their risk of burnout. Several studies have described the psychological impacts of the COVID-19 pandemic on healthcare workers [21], but CPs were rarely included in such studies.

Lebanon, a small country of the Middle East, has one of the world's highest pharmacist-to-population ratios (20.3/10,000 people) [22]. Nonetheless, workforce evaluations revealed major problems about Lebanese pharmacist distribution, practice settings, and regulation. Since CPs sites are privately owned, they are not evenly distributed throughout Lebanese provinces. As per the Lebanese law of 1950, pharmacist registration within the Order of Pharmacists (OPL) is a requirement for practicing the profession of pharmacy. In addition, the payment of an annual fee and the enrollment in the compulsory continuing education program are requisite to preserve their registration. CPs practice is also supervised by inspectors from the OPL in collaboration with inspectors from the Ministry of Public Health (MOPH). Under the Lebanese OPL and the MOPH laws that regulate pharmacy practice, CPs are requested to be present all the time during the pharmacy's working hours. Of note, a technician can dispense a medicine to a patient without consulting the on-duty CPs and Lebanese patients can buy any non-controlled medication despite its classification as a prescription medication in other countries. In addition, CPs have other responsibilities such as storing and supplying adequate stocks of medicines, as well as counseling, educating the public, and promoting disease prevention and infection control. A pharmacy may only be set up with the permission of the Minister of Public Health. The establishment of a community pharmacy should be licensed by the MOPH and this permission is granted only to a Lebanese pharmacist who holds a license to practice pharmacy profession in Lebanon. A non-Lebanese pharmacist from other nationalities is required to meet the same conditions set out for Lebanese pharmacist as well as to be associated to a country that treats Lebanese pharmacists likewise based on an agreement of reciprocity between the two countries. A CP should also be certified for at least 10 years. Of note, the pharmacy certificate obtained outside Lebanon is not approved by the MOPH committee of equivalence unless the study program of the university that awarded it is equivalent to that of the Lebanese institutions [23].

Over the last two years, Lebanon’s economic collapse crisis coupled with political crisis and the COVID-19 pandemic, have led to dreadful consequences on the pharmacy profession [24]. Under such circumstances, it comes as no surprise the closure of more than 200 pharmacies, the shortage in the supply of essential pharmaceutical products and the risk of shut down of additional 1000 pharmacies. It is also worth noting that there has been an upsurge in the occurrence of pharmacy theft, adding to the sufferings of Lebanese CPs. Besides, the economic collapse and the Lebanese currency value steep loss combined with the medicines inflation prices and the imposed lockdown escalate the Lebanese population concerns towards an imminent medicines shortage in the Lebanese market. Turned into panic mode, the Lebanese population experienced an unprecedented pace to purchase medicines. These stressors such as the soaring demand for medicines, limited supply chain, the financial crisis, the threat of COVID-19, and the increased responsibilities created the level of burnout among CPS. Furthermore, precautions measures implemented in the pharmacy setting, managing crowding, and social distancing have been also shown to have the potential to increase work-related stress [25, 26]. With healthcare workers reporting psychological impacts from the COVID-19 pandemic, burnout syndrome has not been assessed among Lebanese CPs. Therefore, it is of great interest to assess the extent of burnout among CPs and to identify its associated factors.

Methods

Study design and population

A national web-based cross-sectional study was conducted among Lebanese CPs over a period of 2 months extending from February 1st till the end of March 2021. Participants were identified via the list of registered CPs provided by the OPL and were electronically invited to participate. Before their enrollment in the study, CPs were contacted via phone call and notified about the survey and its purpose. Upon their agreement to participate, an online questionnaire using a Google form was sent to them via emails or WhatsApp. They were also invited to share with their colleagues the survey link that included a brief explanation of the study purpose and the electronic informed consent.

All CPs of either gender or profile (owner, manager, or staff pharmacist) working in pharmacy setting at the time of the survey, who had access to the internet and who agreed to participate in the study were eligible for participation. These professionals were defined as the pharmacy team. Exclusion criteria were defined as follows: clinical pharmacists, retired CPs, those who were out of the country at the time of the survey, trainees and pharmacy students or other professionals (e.g., dietician, beautician), as well as those who are not currently practicing. Pharmacists who refused to give informed consent were also excluded from the study. There was no age limitation.

All methods were performed following the relevant guidelines and regulations such as the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines for reporting observational studies [27]. Since the study has no foreseeable risks, written consent was obtained in an electronic format. Participants have not received any compensation for their participation in the study.

Ethical consideration

Participation in this survey was voluntary and participants were allowed to withdraw from the study at any time. Electronic informed consent was obtained for each participant. All information was gathered anonymously and handled confidentially. The study design assured adequate protection of study participants. None of the survey questions asked for information that could harm the participant in any way.

Sample size calculation

The digital Raosoft sample size calculator was used to calculate the sample size of the study, based on a total population size of 4185 community pharmacies registered with OPL, a 95% confidence level and an absolute error of 5%, a minimal sample of 352 pharmacists was required.

Instrumentation

A 58-item questionnaire was developed by the study authors and was reviewed by a panel of experts who were asked to evaluate its content validity based on the relevance, coverage, and representativeness of the items. Of the total items, three were rated irrelevant, thus, they were omitted from the questionnaire. Then, the questionnaire was translated to the Arabic language by a bilingual Arabic–English translator whose first language was Arabic. The translator was asked to develop an Arabic version of the questionnaire that can be understood by all Arabic-speaking individuals. A pre-final version of the translation was drafted and was administered as a pilot study to 20 CPs to evaluate the comprehensibility of the questionnaire. After receiving their feedback, minor linguistic edits were made.

The survey consisted of three sections: (a) sociodemographic characteristics; (b) exposure to severe acute respiratory syndrome coronavirus 2 (SARS-COV-2); (c) COVID-19 threat perception scale, and (d) Copenhagen Burnout scale (A-CBI).

  1. Sociodemographic characteristics: gender, age, marital status, profile, residency, education level, health status, history of medical illnesses, health status of people living with the participant, and the presence of an elderly or dependent child at home.

  2. Exposure to SARS-COV-2. CPs were asked to answer on a yes or no basis whether they were frontline workers in COVID-19, have been tested for COVID-9, previously diagnosed as confirmed COVID-19 case, and had a family member or colleague infected by SARS-COV-2.

  3. COVID-19 perceived threat: this tool was developed by Chong et al. to assess the COVID-19 risk perception among HCWs [28]. It consisted of 10 items where nine of these items described HCWs' perception toward COVID-19 threat and one item related to altruistic acceptance of COVID-19 risk. Ratings were given based on a five-point Likert scale (1 = strongly disagree, 2 = disagree, 3 = neutral, 4 = agree, 5 = strongly angry). Responses were dichotomized into positive responses ‘agree’ or ‘strongly agree’, while ‘strongly disagree’, ‘disagree’, and ‘not sure’ were considered negative. In our study, the Cronbach’s alpha of this scale was equal to 0.703.

  4. The Arabic version of Copenhagen Burnout scale A-CBI: the cross culturally adapted 19-item CBI scales by Youssef et al. was used in the current study to evaluate the three aspects of burnout: personal-related (6 items), work-related (7 items), and client-related (6 items) burnout [29]. Twelve items have responses categories according to frequency ranging as follows: (0 = never/almost, 25 = seldom, 50 = sometimes, 75 = often, 100 = always). Seven questions have answers have responses of intensity ranging from ‘a very low degree’ to ‘to a very high degree’. Scores of less than 50 are considered ‘no/low’, 50 to 74 are considered ‘moderate’, 75–99 are high, and a score of 100 is considered ‘severe’ burnout. Moreover, score were dichotomized as follows: a score ˂50 is considered no/low burnout level whereas a score ≥ 50 is considered moderate/severe burnout level. [30]. In the current study, Cronbach’s alpha reliability coefficients of the CBI subscales were high (personal burnout α = 0.91; work-related burnout α = 0.85; and client-related burnout α = 0.89).

Statistical analysis

The generated data on an excel spreadsheet were transferred to the statistical software IBM SPSS® software (Statistical Package for Social Sciences) version 24.0 for analysis. Before analyzing it, the database was weighed according to the governorate where pharmacy is located, based on the list provided by the OPL. Descriptive statistics were reported using frequency with percentages for categorical variables and mean along with standard deviation for continuous variables. For the bivariate analysis of continuous variables, the Chi-2 test was used to compare categorical variables. All variables that showed a p-value < 0.2 in the bivariate analysis were included in the multivariable analysis as independent variables. Four logistic regressions using were conducted to identify the correlates of each of the CBI scales using overall burnout, personal burnout, work-related burnout and client-related burnout, respectively, as dependent variable. A p-value less than 0.05 is considered statistically significant.

Results

Baseline information of the participants

A total of 387 CPs participated in the survey. Of the total, 53.7% were females; 60.5% were married, 43.2% were aged less than 40 years old, and 65.9% were residents of urban areas. Around half of the participants hold a BS degree in pharmaceutical sciences, had less than 10 years of professional experience (56.9%), working more than 40 h per week (59.9%), having a monthly income more than 2 million Lebanese pounds (53.9%) and were pharmacy’ owner (55.3%). Most of surveyed CPs worked in pharmacies located in Mount-Lebanon governorate, which is mainly operating around 50–120 h per week (81.6%). Of note, 77.5% have a good health status. In terms of family members, nearly half of participants had currently a dependent child (55.5%) or were living with the elderly (51.4%) or a family member with comorbidities living with them at home (59.4%). In terms of exposure, 76.7% of them were tested for COVID-19 and 23% were diagnosed with COVID-19. A detailed description of the baseline characteristics of the surveyed CPs is presented in Table 1.

Table 1.

Sociodemographic characteristics of surveyed Lebanese community pharmacists (N = 387)

n %
Gender
 Male 179 46.30%
 Female 208 53.70%
Age (years)
 Less than 40 y 254 65.60%
 ≥ 40 y 133 34.40%
Marital status
 Unmarried* 153 39.50%
 Married 234 60.50%
Pharmacy location
 North and Akkar 48 12.40%
 Mount Lebanon 145 37.50%
 Beirut 60 15.50%
 South and Nabatyeh 79 20.40%
 Bekaa and Baalbeck-Hermel 55 14.20%
Urbanicity (residency)
 Rural 132 34.10%
 Urban 255 65.90%
Years of experience
 0–10 years 220 56.90%
 More than 10 years 167 43.20%
Profile
 Staff pharmacist 135 34.90%
 Owner 214 55.30%
 Manager 38 9.80%
Highest education level
 BS pharmacy 216 55.80%
 Other (Master, PharmD, PhD…) 171 44.20%
Number of hours per week pharmacy is open
 Less than 50 h 40 10.40%
 50–120 h 316 81.60%
 7 days 24/24 h 31 8.00%
Pharmacist working hours
 Less than 40 h
 40 h or more 155 40.10%
Household income 232 59.90%
 < 2 millions 178 46.10%
 > 2 millions 209 53.9%
Health status
 Fair and below 87 22.50%
 Good and above 300 77.50%
Presence of dependent child
 No 172 44.50%
 Yes 215 55.50%
Presence of elderly people at home
 No 188 48.60%
 Yes 199 51.40%
Living with family member with comorbidities
 No 157 40.60%
 Yes 230 59.40%
Ever tested for COVID-19
 No 90 23.30%
 Yes 297 76.70%
Personal history of COVID-19 diagnosis
 No 298 77.00%
 Yes 89 23.00%
Family member/friend ever diagnosed with COVID-19
 No 256 66.10%
 Yes 131 33.90%
Colleague ever diagnosed with COVID-19
 No 35 9.00%
 Yes 352 91.00%

N frequency, % percentage, *Other included divorced or widowed

Description of the scales

The means and standard deviations of personal burnout work-related burnout and client-related burnout scales were 67.17 (SD = 16.82), 67.02 (SD = 14.15), and 69.38 (SD = 20.78), respectively. A detailed description of the scales items is presented in Table 2.

Table 2.

Descriptive statistics of the scales used in the study

# Scale items Mean S.D
TPS Threat perception scale 36.68 1.92
 Threat1 My job puts me at great risk 3.96 0.63
 Threat2 I feel more stress at work 3.86 0.77
 Threat3 I have little control over whether I get infected or not 3.01 0.10
 Threat4 I have little chance of survival if I were to get SARS 2.16 0.48
 Threat5 I think of resigning because of SARS 2.16 0.48
 Threat6 I am afraid that I will pass SARS to others 4.23 0.83
 Threat7 My family and friends are worried they get infected through me 3.85 0.53
 Threat8 People avoid my family because of my work 4.03 0.93
 Threat9 I am afraid of falling ill with SARS-COV-2 3.82 0.72
 ALtru1 I accept the risk of caring for a SARS-COV-2 patient 3.63 0.74
CBI Copenhagen Burnout Inventory Scale 65.34 17.39
Personal burnout 67.17 16.82
 PB1 How often do you feel tired? 66.41 16.56
 PB2 How often you are physically exhausted? 66.41 16.56
 PB3 How often you are emotionally exhausted? 66.41 16.56
 PB4 How often do you think: "I can’t take it anymore"? 69.06 12.48
 PB5 How often do you feel worn out? 67.38 16.88
 PB6 How often do you feel weak and susceptible to illness? 67.38 16.88
Work-related burnout 67.02 14.15
 WB1 Is your work emotionally exhausting? 64.08 13.42
 WB2 Do you feel burnt out because of your work? 68.67 11.18
 8WB3 Does your work frustrate you? 69.12 11.91
 WB4 Do you feel worn out at the end of the working day? 69.77 11.53
 WB5 Are you exhausted in the morning at the thought of another day at work? 66.15 12.24
 WB6 Do you feel that every working hour is tiring for you? 69.51 11.26
 WB7 Do you have enough energy for family and friends during leisure time? R 66.60 12.09
Client burnout 69.38 20.78
 CB1 Do you find it hard to work with clients? 68.27 21.39
 CB2 Do you find it frustrating to work with clients? 62.82 22.39
 CB3 Does it drain your energy to work with clients? 67.67 23.53
 CB4 Do you feel that you give more than you get back when you work with clients? 68.82 24.29
 CB5 Are you tired of working with clients? 72.03 24.98
 CB6 Do you sometimes wonder how long you will be able to continue working with clients? 69.30 21.23

M:mean, SD: standard deviation, R: reversed coding

Risk perceptions and altruistic acceptance of risk during the COVID-19 pandemic

More than 90% of surveyed CPs believed that their job was putting them at risk and were afraid to transmit the COVID-19 to their families and friends. In addition, 86.1% of them felt extra stress at work and 62.1% were afraid of falling ill with COVID-19, while 61.1% were worried that people avoid their families because of their work. More than half of CPs considered they had little control over being infected or not. 53.4% of participants were concerned that their families and friends feared to get infection through them. Only 1.03% of CPs believed that they would die if they get infected and 4.9% thought about resigning because of COVID-19. Most participants (78.8%) altruistically accepted taking the risk of caring for COVID-19 patients (Fig. 1).

Fig. 1.

Fig. 1

Community pharmacists’ perception of COVID-19 threat (N = 387)

Prevalence of burnout among Lebanese community pharmacists

The prevalence of CPs reporting high personal burnout level was 65.9% while 37% and 17.3% of CPs reported high burnout level on workload burnout and client-burnout subscales, respectively. The overall prevalence of CPs reporting moderate or higher burnout level was 89.7% for the client-burnout subscale, followed by personal burnout (77.8%), and work-related burnout (76.8%) (Fig. 2).

Fig. 2.

Fig. 2

Prevalence of burnout among Lebanese community pharmacists (N = 387)

Factors associated with personal burnout

Younger age (aOR = 1.792, 95% CI (1.342–1.904)), female gender (aOR = 2.632, 95% CI (1.913–4.187)), staff pharmacist (aOR = 2.116, 95% CI (1.618–3.807)), working more than 40 h per week (aOR = 1.663, 95% CI (1.321–2.732)), having a dependent child (aOR = 2.632, 95% CI (1.913–4.187)), insufficient sleeping hours (aOR = 3.219, 95% CI (2.013–6.127)), having a colleague diagnosed with COVID-19 (aOR = 1.852, 95% CI (1.347–2.786)) and high perceived COVID-19 threat (aOR = 1.852, 95% CI (1.347–2.786)) were more likely to have moderate-to-high personal burnout level compared to their counterparts. However, being married (aOR = 0.876, 95% CI (0.669 0.942)), having high socioeconomic status (aOR = 0.367, 95% CI (0.218–0.605)), and altruistically accepting the risks of caring for COVID-19 patients (aOR = 0.812, 95% CI (0.623–0.918)) were significantly associated with a lower likelihood of personal burnout level (Table 3).

Table 3.

Factors associated with personal burnout scale among CPs

No/low Moderate to high Confidence interval 95%
n (%) n (%) Total p-value aOR Lower Upper
Gender 0.022
 Male 48 (26.8%) 138 (73.2%) 179 (46.3%) 1.00
 Female 38 (18.3%) 170 (81.7%) 208 (53.7%) 2.632 1.913 4.187
Age (years) 0.023
 ≥ 40 y 50 (37.5%) 83 (62.5%) 133 (34.4%) 1.00
 Less than 40 y 36 (14.2%) 218 (85.8%) 254 (65.6%) 1.792 1.342 1.904
Marital status 0.048
 Single and othera 39 (25.4%) 114 (74.6%) 153 (39.5%) 1.00
 Married/engaged 47 (20%) 187 (80%) 234 (60.5%) 0.876 0.669 0.942
Profile 0.039
 Owner 54 (25.2%) 160 (74.8%) 214 (55.3%) 1.00
 Manager 8 (21.1%) 30 (79.9%) 38 (9.8%) 1.213 0.907 1.813
 Staff pharmacist 24 (17.7%) 111 (82.3%) 135 (34.9%) 2.116 1.618 3.807
Pharmacist working hours 0.026
 Less than 40 h 32 (20.6%) 123 (79.4%) 155 (40.1%) 1.00
 40 h or more 54 (23.2%) 178 (76.8%) 232 (59.9%) 1.663 1.321 2.732
Subjective classification of the current economic status  < 0.001
 Low 49 (16.9%) 242 (87.1%) 278 (46.4%) 1.00
 Middle 16 (21.3% 63 (78.7%) 80 (20.7%) 0.871 0.689 0.914
 High 21 (72%) 187 (89.9%) 29 (43.6%) 0.367 0.218 0.605
Presence of dependent child  < 0.001
 No 66 (38.9%) 106 (61.1%) 172 (44.5%) 1.00
 Yes 20 (9.3%) 195 (90.7%) 215 (55.5%) 4.017 3.818 7.432
Personal history of COVID-19 diagnosis 0.079
 No 70 (23.4%) 228 (76.6%) 298 (77%)
 Yes 16 (17.9%) 73 (82.1%) 89 (23%)
Family member/friend ever diagnosed with COVID-19 0.102
 No 55 (21.5%) 201 (79.5%) 256 (66.1%)
 Yes 31 (23.7%) 100 (76.3%) 131 (33.9%)
Colleague ever diagnosed with COVID-19 0.006
 No 19 (54.3%) 16 (45.7%) 35 (9%) 1.00
 Yes 67 (19.1%) 285 (80.9%) 352 (91%) 4.73 2.782 7.112
Sleeping hours  < 0.001
 ≥ 6 h 54 (24.5%) 166 (75.5%) 220 (56.8%) 1.00
 < 6 h 32 (19.1%) 135 (86.2%) 167 (43.2%) 3.219 2.013 6.127
Altruism 0.042
 Disagree 20 (24.4%) 62 (75.6%) 82 (21.25%) 1.00
 Agree 66 (21.6%) 239 (78.4%) 305 (78.8%) 0.812 0.623 0.918
Threat perception scale 0.032 1.852 1.347 2.786

n frequency, % percentage, aOther included divorced or widowed. C.I: confidence interval, aOR: adjusted odds ratio

Factors associated with work-related burnout

Younger age CPs (aOR = 2.132, 95% CI (1.168–3.005)), staff pharmacist (aOR = 4.12, 95% CI (2.192–6.117)), having extensive working hours (aOR = 1.709, 95% CI (1.221–3.405)), having a dependent child (aOR = 2.361, 95% CI (1.765–3.812)), dealing with COVID-19 cases (aOR = 1.912, 95% CI (1.682–3.829)), working in a pharmacy which is operating more than 50 h per week (aOR = 4.178, 95% CI (2.781–6.553)), having insufficient sleeping hours (aOR = 2.918, 95% CI (1.812–5.218)), having a colleague diagnosed with COVID-19 (aOR = 3.819, 95% CI (2.011–7.415)) and high perception of COVID-19 threat (aOR = 2.853, 95% CI (1.473–3.885) were more likely to have moderate-to-high work-related burnout. However, high socioeconomic status (aOR = 0.367, 95% CI (0.218–0.605)), more than 10 years of experience (aOR = 0.761, 95% CI (0.532–0.898)), altruistically accepting the risks of caring for COVID-19 patients (aOR = 0.722, 95% CI (0.512–0.909)) were significantly associated with a lower likelihood of work-related burnout compared to their counterparts (Table 4).

Table 4.

Factors associated with work-related burnout scale among CPs

No/low Moderate/high 95% Confidence interval
n (%) n (%) Total p-value aOR Lower Upper
Age (years) 0.023
 ≥ 40 y 42 (31.6%) 91 (68.4%) 133 (34.4%) 1.00
 Less than 40 y 48 (18.9%) 206 (91.1%) 254 (65.6%) 2.132 1.168 3.005
Years of experience 0.013
 0–10 years 39 (17.7%) 181 (82.3%) 220 (56.9%) 1.00
 More than 10 years 51 (30.5%) 116 (69.5%) 167 (43.2%) 0.761 0.532 0.898
Profile 0.011
 Owner 65 (30.3%) 149 (69.7%) 214 (55.3%) 1.00
 Manager 14 (36.8%) 24 (63.2%) 38 (9.8%) 1.812 0.923 3.107
 Staff pharmacist 11 (8.2%) 124 (91.8%) 135 (34.9%) 4.12 2.192 6.117
Number of hours per week pharmacy is open  < 0.001
 Less than 50 h 20 (50%) 20 (50%) 40 (10.4%) 1.00
 50–120 h 65 (20.5%) 251 (79.5%) 316 (81.6%) 3.128 2.129 5.338
 7 days 24/24 h 5 (16.1%) 26 (83.9%) 31 (8%) 4.178 2.781 6.553
Pharmacist working hours  < 0.001
 Less than 40 h 58 (37.4%) 97 (62.6%) 155 (40.1%) 1.00
 40 h or more 32 (13.7%) 200 (86.3%) 232 (59.9%) 1.709 1.221 3.405
Presence of underlying condition  < 0.001
 No 73 (24.4%) 225 (75.6%) 298 (77.00%) 1.00
 Yes 17 (19.1%) 72 (80.9%) 89 (23%) 1.821 1.239 3.011
Presence of dependent child  < 0.001
 No 70 (40.7%) 102 (59.3%) 172 (44.5%) 1.00
 Yes 20 (9.3%) 195 (90.7%) 215 (55.5%) 2.361 1.765 3.812
Dealing with COVID-19 case 0.032
 No 60 (29.7%) 142 (70.3%) 202 (48.1%) 1.00
 Yes 30 (16.3%) 155 (83.7%) 185 (51.9%) 1.912 1.682 3.829
Sleeping hours  < 0.001
 ≥ 6 h 64 (29.1%) 156 (70.9%) 220 (56.8%) 1.00
 < 6 h 26 (15.5%) 141 (84.4%) 167 (43.2%) 2.918 1.812 5.218
Subjective classification of the current economic status  < 0.001
 Low 50 (17.9%) 228 (82.1%) 278 (46.4%) 1.00
 Middle 22 (27.5%) 58 (72.5%) 80 (20.7%) 0.871 0.689 1.914
 High 18 (62.1%) 11 (37.9%) 29 (43.6%) 0.367 0.218 0.605
Altruism 0.042
 Disagree 66 (80.4%) 16 (19.6%) 82 (21.25%) 1.00
 Agree 24 (7.9%) 281 (92.1%) 305 (78.8%) 0.722 0.512 0.909
Threat perception scale 0.016 2.853 1.472 3.885
Colleague ever diagnosed with COVID-19 0.001
 No 20 (57.1%) 15 (42.9%) 35 (9%) 1.00
 Yes 70 (19.9%) 282 (80.1%) 352 (91%) 3.819 2.011 7.415

n frequency, % percentage, *Other included divorced or widowed

Factors associated with client-related burnout

Younger age (aOR = 1.792, 95% CI (1.342–1.904)), staff pharmacists (aOR = 3.021, 95% CI (1.892–5.327)), working more than 40 h per week (aOR = 4.302, 95% CI (2.918–7.503)), taking care of COVID-19 cases (aOR = 3.781, 95% CI (1.461–7.412)) and high COVID-19 threat perception (aOR = 2.032, 95% CI (1.283–4.066)) were significantly associated with moderate-to-high client-related burnout level. However, altruistically accepting the risks of caring for COVID-19 patients (aOR = 0.582, 95% CI (0.381–0.765)) was significantly associated with a lower likelihood of client-related burnout level (Table 5).

Table 5.

Factors associated with the client-related burnout scale

No/low Moderate/high Confidence interval
n (%) n (%) Total p-value aOR Lower Upper
Age (years) 0.023
 ≥ 40 y 31 (23.3%) 102 (76.7%) 133 (34.4%) 1.00
 Less than 40 y 39 (15.4%) 293 (84.6%) 254 (65.6%) 1.792 1.342 1.904
Profile 0.021
 Owner 53 (24.7%) 161 (75.3%) 214 (55.3%) 1.00
 Manager 7 (18.4%) 31 (81.6%) 38 (9.8%) 1.322 0.879 3.512
 Staff pharmacist 10 (7.4%) 123 (92.6%) 135 (34.9%) 3.021 1.892 5.327
Pharmacist working hours  < 0.001
 Less than 40 h 49 (31.6%) 106 (68.4%) 155 (40.1%) 1.00
 40 h or more 21 (9.1%) 211 (89.9%) 232 (59.9%) 4.302 2.918 7.503
Taking care of COVID-19 cases 0.012
 No 65 (32.2%) 137 (67.8%) 202 (48.1%) 1.00
 Yes 5 (2.7%) 180 (97.3%) 185 (51.9%) 3.781 1.467 7.412
Altruism
 Disagree 8 (9.5%) 58 (91.5%) 82 (21.25%) 1.00
 Agree 62 (20.3%) 243 (79.7%) 305 (78.8%) 0.582 0.381 0.765
Threat perception 0.043 2.032 1.283 4.066

Discussion

To the best of our knowledge, this study is the first nationwide survey assessing the prevalence of burnout among CPs during the COVID-19 pandemic and examining its associated factors. The prevalence of moderate-to-high personal, work-related and client-related burnout was 77.8%, 76.8, and 89.7%, respectively. Younger age, staff pharmacist, working more than 40 h per week, high perceived COVID-19 threat were associated with a moderate-to-high likelihood of burnout in all three domains. However, altruistically accepting the risks of caring for COVID-19 patients was the only variable that was associated with a lower likelihood of burnout in all three domains.

Our findings showed that the majority of Lebanese CPs suffered from burnout in all the three domains. This was predictable since Lebanese CPs were stranded under a perfect storm that could instigate burnout. The alarming level of burnout among CPs in all three domains stressed the importance of urgent action to tackle such epidemic. Due to the uncertainty of the length of the current pandemic and the ongoing economic crisis, no one can neglect the considerable lasting impact of this syndrome. Our findings were higher than those reported in prior studies. A study conducted among CPs showed that 74.9% of respondents experienced burnout in at least 1 of the 3 subscales of the MBI-HSS [31]. A study conducted in Serbia reported that 44.4% of CPshad high levels of burnout [32]. A systematic review found the prevalence of burnout in pharmacists ranged from 19 to 37% [16]. Another study conducted among pharmacists in Saudi Arabid showed that 25.16% of pharmacists had high emotional exhaustion, 55.97% had high depersonalization, and 63.52% had low scores for personal accomplishment [33]. However, such comparison should be cautious since different scales were used.

Younger age was found to be associated with higher level of burnout in all three domains. This was consistent with the findings of a study conducted in United States by Jones et al. among hospital clinical pharmacy practitioners [8]. This could be explained by the fact that younger pharmacists have the most workload, as the first few years of a pharmacist's career can be filled with night shifts which can contribute to a feeling of burnout. Regarding the role of gender on the development of burnout among CPs, our results showed that female CPs were more likely to experience high level of personal burnout compared to males. Our results were consistent with the findings of a nationwide survey performed among the American Pharmaceutical Association membership which revealed higher level of burnout in women compared to men pharmacists [34].

Compared to pharmacy owners, staff pharmacists had higher odds of burnout in all three domains. These results were in line with the findings of an Italian study which revealed that CPs most exposed to exhaustion were those who played the role of employee compared to those who held the role of holder, manager or other management roles [35]. Such finding was expected, as the staff pharmacists experience a relevant workload and were more exposed to clients than managers and owners, especially in larger pharmacies [36].

With regard to marital status, married CPs were found less likely to suffer from higher burnout compared to unmarried CPs. Consistent with other studies, unmarried respondents had significantly higher exhaustion than married [37]. This could be explained by the fact that CPs receiving support from their partners experience less burnout when compared to those who do not. Of note, one of the suggested ideas found in the literature to overcome burnout was the building of support systems through family to enhance self-esteem and reduce burnout.

With regard to sleeping hours, our study showed that sleeping more than 6 h daily was associated with lower level of personal and work-related burnout. Of note, the role of extensive working hours and sleep deprivation, was reported as risk factor for burnout among CPs in several studies especially when working in pharmacies operating round the clock with night shift [8, 38]. With the economic collapse and the steep loss of the value of the Lebanese currency combined with the inflation of the drug prices, an unprecedented race to purchase medicines from pharmacies was reported. Hence, Lebanese CPs are facing intense workload, extensive working hours, which eventually impact physicians sleeping hours and increase burnout levels [39, 40]. A study conducted prior to the pandemic showed that 33% of the HCWs were screened positive for the sleeping disorder and this was associated with fourfold bigger odds of burnout [41]. These results were in line with the findings among Saudi Arabian pharmacists where sleeping hours per day were significantly correlated with burnout. Of note, sleep disturbances was positively associated with impaired performance, emotional changes, tiredness, loss of concentration, and mood disorders as anxiety or depression [42]. In addition to all of the above, high socioeconomic status (aOR = 0.452, 95% CI (0.238–0.611)) was associated with lower personal and work-related burnout level. Several studies showed a correlation between income satisfaction and burnout. Other studies showed that low annual salary was associated with higher burnout level [37]. In terms of living conditions, having a dependent child was associated with higher personal and work-related burnout level. This could be due to the fears expressed by CPs to transfer the infection to their families. Similarly higher perception of COVID-19 threat, in terms of catching the infection, transmission of the COVID-19, stigmatization of family was associated with higher level of burnout. These findings were not surprising as CPs believed that their job was putting them at risk and were afraid to transmit the infection to others including their families.

Several limitations should be acknowledged in our study. First, the cross-sectional design of our study does not allow us to infer causality or temporal relationship. Secondly, selection bias is possible due to the snowball technique used for data collection which limits the generalizability of the findings. To overcome this limitation, our data were weighed by geographical location according to the list of CPs provided by the OPL. Thirdly, the collected data were also based on self-reported information which makes it prone to social desirability and might drive the results towards the null, leading to underestimation of some associations. Fourth, we were unable to assess the pandemic's impact on burnout due to a lack of data on pre-COVID burnout among CPs.

Conclusion

An alarming prevalence of personal, work-related and client-related burnout was revealed among Lebanese CPs. The present study identified several modifiable factors that affect burnout among CPs in Lebanon. This study has many implications for practice and provides a framework for establishing policy interventions to reduce burnout levels among Lebanese CPs. Preventive strategies and interventions on individual and organizational basis like focusing on work–life balance, minimizing the level of chronic stress, increasing work satisfaction, peer support, counseling and self-care are recommended. Further studies exploring the independent and combined effect of the economic crisis on burnout levels among Lebanese CPs are highly recommended.

Acknowledgements

The authors would like to thank all community pharmacists who accepted to be part of this study.

Authors' contributions

DY and LAA were involved with study conception and design, data collection and analysis, drafted and revised the manuscript. JY was involved with study conceptualization and design, drafting and revising the article. HS was involved in the revision of the manuscript. All authors read and approved the final manuscript.

Funding

This research received no external funding.

Data availability

The datasets generated during the current study are not publicly available, but are available from the corresponding author on reasonable request.

Declarations

Ethics approval and consent to participate

Informed consent for participating in the study was obtained digitally through Google Forms from all subjects, and all methods were carried out in accordance with the relevant guidelines and national regulations for the Non-clinical studies. Specifically, at the beginning of the questionnaire, participants were asked whether they agree to participate in the research in order to be included in the study. Participants were also informed that their participation was voluntary and that they had the right to leave at any time without providing any explanation. No incentives were provided to the study participants.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests and they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Soler JK, et al. Burnout in European family doctors: the EGPRN study. Fam Pract. 2008;25(4):245–265. doi: 10.1093/fampra/cmn038. [DOI] [PubMed] [Google Scholar]
  • 2.Poghosyan L, Aiken LH, Sloane DM. Factor structure of the Maslach burnout inventory: an analysis of data from large scale cross-sectional surveys of nurses from eight countries. Int J Nurs Stud. 2009;46(7):894–902. doi: 10.1016/j.ijnurstu.2009.03.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Hall LH, et al. Healthcare staff wellbeing, burnout, and patient safety: a systematic review. PLoS ONE. 2016;11(7):e0159015–e0159015. doi: 10.1371/journal.pone.0159015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Bookwalter CM. Challenges in community pharmacy during COVID-19: the perfect storm for personnel burnout. US Pharm. 2021;46(5):28–31. [Google Scholar]
  • 5.Sabater-Galindo M, et al. Patients' expectations of the role of the community pharmacist: Development and testing of a conceptual model. Res Social Adm Pharm. 2017;13(2):313–320. doi: 10.1016/j.sapharm.2016.04.001. [DOI] [PubMed] [Google Scholar]
  • 6.Magola E, Willis SC, Schafheutle EI. Community pharmacists at transition to independent practice: Isolated, unsupported, and stressed. Health Soc Care Community. 2018;26(6):849–859. doi: 10.1111/hsc.12596. [DOI] [PubMed] [Google Scholar]
  • 7.Durham, M.E., P.W. Bush, and A.M. Ball, Evidence of burnout in health-system pharmacists. American Journal of Health-System Pharmacy, 2018. 75 (23_Supplement_4): S93-S100. [DOI] [PubMed]
  • 8.Jones GM, et al. Factors associated with burnout among US hospital clinical pharmacy practitioners: results of a nationwide pilot survey. Hosp Pharm. 2017;52(11):742–751. doi: 10.1177/0018578717732339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Dugani S, et al. Prevalence and factors associated with burnout among frontline primary health care providers in low-and middle-income countries: a systematic review. Gates Open Res. 2018;2:1. doi: 10.12688/gatesopenres.12779.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Elbarazi I, et al. Prevalence of and factors associated with burnout among health care professionals in Arab countries: a systematic review. BMC Health Serv Res. 2017;17(1):1–10. doi: 10.1186/s12913-017-2319-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.West CP, Dyrbye LN, Shanafelt TD. Physician burnout: contributors, consequences and solutions. J Intern Med. 2018;283(6):516–529. doi: 10.1111/joim.12752. [DOI] [PubMed] [Google Scholar]
  • 12.Golkar A, et al. The influence of work-related chronic stress on the regulation of emotion and on functional connectivity in the brain. PLoS ONE. 2014;9(9):e104550. doi: 10.1371/journal.pone.0104550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Papathanasiou IV. Work-related mental consequences: implications of burnout on mental health status among health care providers. Acta Inform Med. 2015;23(1):22–28. doi: 10.5455/aim.2015.23.22-28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Dyrbye LN, et al. Burnout and suicidal ideation among U.S. medical students. Ann Intern Med. 2008;149(5):334–41. doi: 10.7326/0003-4819-149-5-200809020-00008. [DOI] [PubMed] [Google Scholar]
  • 15.Shanafelt TD, et al. Special report: suicidal ideation among American surgeons. Arch Surg. 2011;146(1):54–62. doi: 10.1001/archsurg.2010.292. [DOI] [PubMed] [Google Scholar]
  • 16.McQuade BM, et al. Feeling the burn? A systematic review of burnout in pharmacists. J Am Coll Clin Pharm. 2020;3(3):663–675. doi: 10.1002/jac5.1218. [DOI] [Google Scholar]
  • 17.Patel SK, et al. Prevalence and risk factors of burnout in community pharmacists. J Am Pharm Assoc. 2021;61(2):145–150. doi: 10.1016/j.japh.2020.09.022. [DOI] [PubMed] [Google Scholar]
  • 18.Nazar H, et al. A systematic review of the role of community pharmacies in improving the transition from secondary to primary care. Br J Clin Pharmacol. 2015;80(5):936–948. doi: 10.1111/bcp.12718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Blumenthal, D., et al., Covid-19—implications for the health care system. 2020, Mass Medical Soc. [DOI] [PubMed]
  • 20.Visacri MB, Figueiredo IV, de Mendonça-Lima T. Role of pharmacist during the COVID-19 pandemic: a scoping review. Res Soc Admin Pharm. 2021;17(1):1799–1806. doi: 10.1016/j.sapharm.2020.07.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Yan L, et al. The psychological impact of COVID-19 pandemic on health care workers: a systematic review and meta-analysis. Front Psychol. 2021;12:2382. doi: 10.3389/fpsyg.2021.626547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Alameddine MK, Bou-Karroum MA. Upscaling the pharmacy profession in Lebanon: workforce distribution and key improvement opportunities. Human Resourc Health. 2019;17(1):47. doi: 10.1186/s12960-019-0386-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Lebanese Order of Pharmacists website. [accessed December 2 2021. www.opl.org.lb. Accessed 2 Dec 2021.
  • 24.Abi-Rached, J. and I. Diwan, The Socioeconomic Impact of COVID-19 on Lebanon: A Crisis Within Crises. Published June 2020. 2020.
  • 25.Visacri MB, Figueiredo IV, Lima TM. Role of pharmacist during the COVID-19 pandemic: A scoping review. Res Soc Admin Pharm. 2021;17(1):1799–1806. doi: 10.1016/j.sapharm.2020.07.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Austin Z, Gregory P. Resilience in the time of pandemic: the experience of community pharmacists during COVID-19. Res Social Adm Pharm. 2021;17(1):1867–1875. doi: 10.1016/j.sapharm.2020.05.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.von Elm E, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4(10):e296. doi: 10.1371/journal.pmed.0040296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Chong M-Y, et al. Psychological impact of severe acute respiratory syndrome on health workers in a tertiary hospital. Br J Psychiatry. 2004;185(2):127–133. doi: 10.1192/bjp.185.2.127. [DOI] [PubMed] [Google Scholar]
  • 29.Kristensen TS, et al. The Copenhagen Burnout Inventory: a new tool for the assessment of burnout. Work Stress. 2005;19(3):192–207. doi: 10.1080/02678370500297720. [DOI] [Google Scholar]
  • 30.Creedy D, et al. Prevalence of burnout, depression, anxiety and stress in Australian midwives: a cross-sectional survey. BMC Pregnancy Childbirth. 2017;17(1):1–8. doi: 10.1186/s12884-016-1212-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Patel SK, et al. Prevalence and risk factors of burnout in community pharmacists. J Am Pharm Assoc. 2021;61(2):145–150. doi: 10.1016/j.japh.2020.09.022. [DOI] [PubMed] [Google Scholar]
  • 32.Jocic D, Krajnovic D. State anxiety, stress and burnout syndrome among community pharmacists: relation with pharmacists’ attitudes and beliefs. Indian J Pharm Educ Res. 2014;48(2):9–15. doi: 10.5530/ijper.48.2.3. [DOI] [Google Scholar]
  • 33.Almodaimegh, H., Prevalence of burnout among hospital pharmacists at National Guard Hospital in Riyadh, Saudi Arabia. 2020.
  • 34.Lahoz MR, Mason HL. Burnout among pharmacists. Am Pharm. 1990;8:28–32. doi: 10.1016/S0160-3450(16)36003-2. [DOI] [PubMed] [Google Scholar]
  • 35.Protano C, et al. A cross-sectional study on prevalence and predictors of burnout among a sample of pharmacists employed in pharmacies in central Italy. BioMed Res Int. 2019. 2019. [DOI] [PMC free article] [PubMed]
  • 36.Chui MA, Mott DA. Community pharmacists’ subjective workload and perceived task performance: a human factors approach. J Am Pharm Assoc. 2012;52(6):e153–e160. doi: 10.1331/JAPhA.2012.11135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Gupchup G. Burnout in a sample of HMO pharmacists using the Maslach Burnout Inventory. J Manag Care Pharm. 1998;4(5):495–503. doi: 10.18553/jmcp.1998.4.5.495. [DOI] [Google Scholar]
  • 38.El-Ibiary SY, Yam L, Lee KC. Assessment of burnout and associated risk factors among pharmacy practice faculty in the United States. Am J Pharm Educ. 2017;81:4. doi: 10.5688/ajpe81475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Gaither CA, Nadkarni A. Interpersonal interactions, job demands and work-related outcomes in pharmacy. Int J Pharm Pract. 2012;20(2):80–89. doi: 10.1111/j.2042-7174.2011.00165.x. [DOI] [PubMed] [Google Scholar]
  • 40.Chui MA, Look KA, Mott DA. The association of subjective workload dimensions on quality of care and pharmacist quality of work life. Res Social Adm Pharm. 2014;10(2):328–340. doi: 10.1016/j.sapharm.2013.05.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Shanafelt TD. Enhancing meaning in work: a prescription for preventing physician burnout and promoting patient-centered care. JAMA. 2009;302(12):1338–1340. doi: 10.1001/jama.2009.1385. [DOI] [PubMed] [Google Scholar]
  • 42.Söderström M, et al. Sleep and sleepiness in young individuals with high burnout scores. Sleep. 2004;27(7):1369–1377. doi: 10.1093/sleep/27.7.1369. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The datasets generated during the current study are not publicly available, but are available from the corresponding author on reasonable request.


Articles from Journal of Pharmaceutical Policy and Practice are provided here courtesy of Taylor & Francis

RESOURCES